← FDA Drug Approvals (Drugs@FDA)

ABLAVAR

NDA · New Drug Application · Sponsor: LANTHEUS MEDCL · Approved 2008-12-22

Drug application

FDA Application #

NDA021711

Application type

New Drug Application

Brand name

ABLAVAR

Generic name

Gadofosveset Trisodium

Active ingredients

GADOFOSVESET TRISODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

LANTHEUS MEDCL

First approval

2008-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown